Clinical Trials Directory

Trials / Unknown

UnknownNCT01245075

Deep Brain Stimulation of the Nucleus Accumbens as a Novel Treatment in Severe Opioid Addiction

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Jens Kuhn · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to assess the efficacy of bilateral deep brain stimulation (DBS) of the Nucleus accumbens (NAc) as a novel treatment in severe opioid addiction. The included patients have been treated so far with a substitute in form of methadone. Our hypothesis is that bilateral DBS of the NAc will significantly reduce the craving for heroin and thus enable the patients to decrease their Levomethadone-dosage substantially.

Conditions

Interventions

TypeNameDescription
OTHERDeep brain stimulationDeep brain stimulation on
OTHERPlacebodeep brain stimulation off

Timeline

Start date
2011-01-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2010-11-22
Last updated
2016-12-07

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01245075. Inclusion in this directory is not an endorsement.